Key facts
- It has raised $1.4M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Chushang Investment, Hubei Guoxin Semiconductor Industry Fund, Lirong Yuanchang Investment, Luojia Capital, Wuhan Planck Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Terapines Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Terapines Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Terapines Technology
Developer of reduced instruction set computer toolchains and operating systems designed to provide hardware and software co-design solutions. The company offers compilers and simulators, hardware-software co-design solutions, therebyproviding clients with solutions spanning hardware-software co-design, DSA and embedded development tools, automotive safety code detection and ROS operating systems.
- Sector
- Information Technology
- HQ
- Wuhan, China
- Founded
- 2019
- Employees
- 5
- Website
- terapines.com/
- Ownership
- Privately Held (backing)
Terapines Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Terapines Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Terapines Technology in its N-PORT filings yet. We sweep new filings monthly.